(Q48362916)

11 February 2018

title

Bupropion effects on high-fat diet-induced steatohepatitis and endothelial dysfunction in rats: role of tumour necrosis factor-alpha (English)

1 reference

11 February 2018

0 references

0 references

Mai Ahmed

1

1 reference

11 February 2018

Wesam M El-Bakly

2

1 reference

11 February 2018

Ahmed M Zaki

3

1 reference

11 February 2018

Lobna F abd Alzez

4

1 reference

11 February 2018

Osama El serafi

5

1 reference

11 February 2018

publication date

29 January 2014

1 reference

11 February 2018

Journal of Pharmacy and Pharmacology

published in

1 reference

11 February 2018

volume

66

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

793-801

1 reference

11 February 2018

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Metabolic syndrome and risk factors for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Bupropion: pharmacology and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Bupropion for weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Functional foods for dyslipidaemia and cardiovascular risk prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Diets enriched in sucrose or fat increase gluconeogenesis and G-6-Pase but not basal glucose production in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Long term highly saturated fat diet does not induce NASH in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Free radicals in diabetic endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12213

21 January 2018

Identifiers

DOI

10.1111/JPHP.12213

1 reference

11 February 2018

1 reference

11 February 2018